Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma
2019 · Blood · 66 citations
https://doi.org/10.1182/blood.2019000626
Y
Yu Zeng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
1.2K
Citations
18
h-index
28
i10-index
Yu Zeng is an academic researcher from Tongji University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Lung Cancer Treatments and Mutations. The author has an h-index of 18, co-authored 66 publications.
ORCID: 0000-0002-9415-0610Papers by this author
worksREGγ is associated with multiple oncogenic pathways in human cancers
2012 · BMC Cancer · 59 citations
https://doi.org/10.1186/1471-2407-12-75
Role of CD47 in tumor immunity: a potential target for combination therapy
2022 · Scientific Reports · 57 citations
https://doi.org/10.1038/s41598-022-13764-3
Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis
2015 · Scientific Reports · 47 citations
https://doi.org/10.1038/srep17638
Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity
2024 · Cell Reports Medicine · 26 citations
https://doi.org/10.1016/j.xcrm.2024.101533
Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What’s the diagnosis?
2012 · Diagnostic Pathology · 9 citations
https://doi.org/10.1186/1746-1596-7-167
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat